These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 20614656)

  • 1. [Use of vasobral in therapy of central nervous system pathology in children of early age].
    Zaĭtseva IN
    Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(1):92-4. PubMed ID: 20614656
    [No Abstract]   [Full Text] [Related]  

  • 2. [The influence of alpha-dihydroergocryptine derivatives on psychomotor manifestations in Parkinson disease].
    Sadekov RA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2000; 100(12):43-5. PubMed ID: 11195537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Experience in the administration of vasobral in sensorineural vascular hypoasusis].
    Grinshteĭn AB; Shnaĭder NA; Kromm OK; Pavlovskaia MV
    Vestn Otorinolaringol; 2001; (2):39-41. PubMed ID: 11338557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Preventive treatment of migraine with vasobral: a multicenter trial].
    Tabeeva GR; Azimova IuE
    Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(11 Pt 2):26-30. PubMed ID: 21389936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Vasobral in the treatment of initial atherosclerotic circulatory encephalopathy].
    Shprakh VV; Molokov DD; Tatarinova MB; Burdukovskaia NL
    Zh Nevrol Psikhiatr Im S S Korsakova; 1996; 96(2):39-40. PubMed ID: 8754338
    [No Abstract]   [Full Text] [Related]  

  • 6. [The use of vasobral in patients with chronic cerebrovascular disorders].
    Kamchatnov PR
    Zh Nevrol Psikhiatr Im S S Korsakova; 2011; 111(10 Pt 1):70-2. PubMed ID: 22500318
    [No Abstract]   [Full Text] [Related]  

  • 7. [Vasobral in the treatment of brain lesions: views of physicians and patients].
    Kamchatnov PR
    Zh Nevrol Psikhiatr Im S S Korsakova; 2013; 113(1):23-5. PubMed ID: 23528488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Vasobral and stabilized cerebral vascular complication: hemodynamic and psychometric study].
    Poncin-Lafitte M; Migeon P; Rancurel G; Rapin JR
    Ann Radiol (Paris); 1987; 30(6):425-30. PubMed ID: 3129979
    [No Abstract]   [Full Text] [Related]  

  • 9. [Efficacy of the combination drug vasobral in chronic vascular encephalopathy].
    Levin OS; Barantsevich ER; Belskaya GN; Vasenina EE; Kopishinskaya SV; Lukashevich IG; Ostroumova OD; Psokhina OV; Radiuk MA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2014; 114(10):25-9. PubMed ID: 25591512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Assessment of quality of life and treatment adherence in patients with dizziness treated with vasobral].
    Lebedeva AV; Kamchatnov PR; Burd SG; Prikazchikov SV; Cherkasova AE; Solovyeva TY
    Zh Nevrol Psikhiatr Im S S Korsakova; 2019; 119(2):28-34. PubMed ID: 30874523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maintaining alertness and performance during sleep deprivation: modafinil versus caffeine.
    Wesensten NJ; Belenky G; Kautz MA; Thorne DR; Reichardt RM; Balkin TJ
    Psychopharmacology (Berl); 2002 Jan; 159(3):238-47. PubMed ID: 11862356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A dose-response study with dihydroergotoxine mesylate in cerebrovascular disturbances.
    Yoshikawa M; Hirai S; Aizawa T; Kuroiwa Y; Goto F; Sofue I; Toyokura Y; Yamamura H; Iwasaki Y
    J Am Geriatr Soc; 1983 Jan; 31(1):1-7. PubMed ID: 6336765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A thioridazine-dihydroergotoxine combination in the treatment of senile pruritus].
    Polenghi M; Colombo MD; Barcella ML; Perego M
    G Ital Dermatol Venereol; 1989 Sep; 124(9):LI-LIII. PubMed ID: 2635137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Long-term follow up of central nervous system leukemia in children (author's transl)].
    Yokoyama T; Fujimoto T; Ito M; Furusho K; Kin H; Hasegawa A
    Rinsho Ketsueki; 1979 Mar; 20(3):246-52. PubMed ID: 439414
    [No Abstract]   [Full Text] [Related]  

  • 15. [Inhibition of post-partum physiological milk secretion by caffeine dihydroergocryptine and dihydroergotoxine].
    Elsener M; Ferrafiat M; de Bruyn M; Jouhet P; Robert Y; Rouge PE
    Rev Fr Gynecol Obstet; 1988 Nov; 83(11):697-701. PubMed ID: 3144727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of stadol NS and fiorinal with codeine.
    Sohn RS
    Headache; 1999 Feb; 39(2):137-8. PubMed ID: 18564449
    [No Abstract]   [Full Text] [Related]  

  • 17. Survival without disability to age 5 years after neonatal caffeine therapy for apnea of prematurity.
    Schmidt B; Anderson PJ; Doyle LW; Dewey D; Grunau RE; Asztalos EV; Davis PG; Tin W; Moddemann D; Solimano A; Ohlsson A; Barrington KJ; Roberts RS;
    JAMA; 2012 Jan; 307(3):275-82. PubMed ID: 22253394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modafinil vs. caffeine: effects on fatigue during sleep deprivation.
    Wesensten NJ; Belenky G; Thorne DR; Kautz MA; Balkin TJ
    Aviat Space Environ Med; 2004 Jun; 75(6):520-5. PubMed ID: 15198278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Study of the therapeutic action of Vasobral in ORL pathology].
    Pech A; Cannoni M; Zanaret M
    J Fr Otorhinolaryngol Audiophonol Chir Maxillofac; 1984 Mar; 33(3):149-52. PubMed ID: 6425452
    [No Abstract]   [Full Text] [Related]  

  • 20. The effects of caffeine and aspirin on mood and performance.
    Lieberman HR; Wurtman RJ; Emde GG; Coviella IL
    J Clin Psychopharmacol; 1987 Oct; 7(5):315-20. PubMed ID: 3680601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.